ACADIA Pharmaceuticals (ACAD) Company Statistics | The Fly

Search...

/

Dashboard

Charting

KPIs

Stock Screener

ETF Screener

Earnings Calendar

Events Calendar

Syndicate

Street Research

Portfolios

Alert Settings

© 2026 The Fly Inc.

The Fly Cast

Press play to listen

©

ACADIA Pharmaceuticals (ACAD) Company Statistics | The Fly

ACADIA Pharmaceuticals

· ACAD

Dashboard

Financials

KPIs

Ratios

Transcripts

Valuation

Statistics

3.437 B

+0.80%

General

Market Cap: $3.44B
Enterprise Value: $3.13B
Shares Outstanding: 171,240,000
Dividend: —
Employees: —
Revenue Per Employee: —

Fundamental Ratios (TTM)

Gross Margin: 91.13%
Operating Margin: 7.59%
Net Profit Margin: 33.42%
FCF Margin: 15.32%
ROA: 21.83%
ROE: 32.39%
ROIC: 6.19%
Current Ratio: 3.39
Debt-to-Equity: 0.06
Revenue Per Employee: —

Valuation (TTM)

P/E: 9.07
PEG: 0.13
P/S: 3.02
P/FCF: 19.75
P/B: 2.64
EV/EBITDA: 26.98

Growth

Rev 1Y: 11.87%

Income Statement (TTM)

Revenue: $1.14B
Gross Margin: 91.13%
Operating Expenses: $951.3M
Operating Income: $86.37M
Net Profit: $380.48M

Balance Sheet

Rev 1Y Fwd Est

18.72%

Rev 3Y (CAGR)

27.48%

Rev 5Y (CAGR)

19.39%

Rev 10Y (CAGR)

165.75%

EPS 1Y

68.38%

EPS 1Y Fwd Est

-73.10%

EPS 3Y (CAGR)

—

EPS 5Y (CAGR)

—

EPS 10Y (CAGR)

—

Cash and Equivalents: $384.99M
Working Capital: $863.11M
Total Assets: $1.74B
Net Debt: -$311.13M
Total Liabilities: $436.29M
Total Equity: $1.31B

Cash Flow Statement (TTM)

Cash Flow from Operations: $194.3M
Cash Flow from Investing: -$11.19M
Cash Flow from Financing: $51.05M
Free Cash Flow: $174.39M
Capital Expenditures: $19.91M